First Dutch Innovations, the new name for TNO Companies bv, will launch today its operations. The Consumer and Market Authority (ACM) recently granted approval for the acquisition of TNO Companies by Peter Goedvolk/First Dutch. TNO will retain a minority stake. First Dutch Innovations has appointed Gina van der Werf Chief Executive Officer.
First Dutch Innovations is committed to the develop and grow innovative companies in the main focus areas: Life Sciences, Sustainable Energy and TIC (Testing, Inspection and Certification) markets enabling innovation in the Netherlands in a sustainable way. Moreover, the company has the explicit goal to increase employment in the Dutch innovative sector.
Gina van der Werf, CEO of First Dutch Innovations: “At First Dutch Innovations innovative power and entrepreneurship converge. We are planning to bring several new valorisations to market each year and to further develop existing companies within the Innovations concept. In a time when many Dutch companies are bought by foreign companies, it is crucial to continue the development of knowledge and bring valorisations to the Dutch market.”
First Dutch Innovations will work in close collaboration with TNO and the other knowledge based institutions in the Netherlands to create a central platform in which knowledge development and entrepreneurship can be merged.
First Dutch Innovations currently has 24 innovative companies with approximately 900 employees. This provides the basis for the expansion of the platform with more innovative companies within the focus areas. First Dutch Innovations will continue to look for enterprising disruptors that fit this profile.
More information: www.firstdutchinnovations.nl.
Proudly we would like to share an article of Clermont Ferrand which gives you a great overview of our TNO gastroIntestinal Model (TIM).
The TIM-1 and tiny-TIM systems simulate the dynamic conditions in the stomach and small intestine, whereas the TIM-2 system simulates the large intestine.
Curious to learn more about our TIM systems? Please do not hesitate to contact us: email@example.com.
Triskelion will be attending the SOT meeting this year like any other year.
We are dedicated to assist you in the area of toxicology, analytical chemistry, risk assessment and registration services for the Chemicals, Pharmaceuticals, Food & Feed industries.
Visit us at stand #2244 in the exhibition hall or make an appointment upfront: firstname.lastname@example.org.
We will be accompanied by experts in key disciplines of toxicology.
We look forward to seeing you in Baltimore, Maryland.
Check out the program now!
The 6th TIM User Group Meeting wil be centered around new applications of the advanced gastric compartment in food and pharma and the use of TIM within the emerging field of microbiome research. As our contribution to accelerate in vitro gastrointestinal research we have developed the next generation of TIM systems. We proudly present its technical features and validation.
The TIM User Group Meeting will provide an excellent opportunity to network with other TIM Users and with colleagues from academia as well as leading food and pharmaceutical companies.
Save the date! Join us on the 11-12 May 2017.
Venue: The College Hotel, Roelof Hartstraat 1, 1071 VE Amsterdam.
To register, please contact: email@example.com.
By Lynda Searby, 08-Jul-2016
Development of an in vitro model that mimics the gastrointestinal tract is one of the ways in which Biofortis and Triskelion hope to help further research into the relationship between the gut microbiome and immune health, under a new partnership.